Heron Therapeutics Inc (FRA:AXD2)
€ 1.6 -0.027 (-1.66%) Market Cap: 246.88 Mil Enterprise Value: 349.30 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Q2 2023 Heron Therapeutics Inc Earnings Call Transcript

Aug 14, 2023 / 08:30PM GMT
Release Date Price: €1.46 (-6.41%)
Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call. As a reminder, this conference is being recorded.

Now I would like to turn the call over to Jeff Cohn, Executive Director, Assistant General Counsel and Assistant Secretary. Please proceed.

Jeff Cohn
Heron Therapeutics, Inc. - Executive Director, Assistant General Counsel & Assistant Secretary

Thank you, Krista, and good afternoon, everyone. Thank you for joining us this afternoon on the Heron Therapeutics conference call to discuss the company's financial results for the second quarter ended June 30, 2023. With me today from Heron are Craig Collard, Chief Executive Officer; Ira Duarte, Executive Vice President, Chief Financial Officer; and Bill Forbes, Executive Vice President, Chief Development Officer.

For those of you participating via conference call, slides are made available via webcast and can also be accessed via the Investor Relations page of our website following the conclusion of today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot